Table 1 Univariate analysis of risk factors in 109 COVID-19 patients with cancer

 Male

19 (31.2)

42 (68.9)

REF

 Female

13 (27.1)

35 (72.9)

0.82

0.36–1.89

0.64

  ≤ 49 years

7(31.8)

15(68.2)

REF

 50–64 years

8(22.9)

27(77.1)

0.64

0.19–2.01

0.46

 65–79 years

10(26.3)

28(73.7)

0.77

0.24–2.42

0.65

  ≥ 80 years

7(50.0)

7(50.0)

2.14

0.54–8.51

0.28

 0

25 (33.3)

50 (66.7)

REF

 1

4 (22.2)

14 (77.8)

0.57

0.17–1.92

0.36

  > 1

3 (18.8)

13 (81.3)

0.46

0.12–1.77

0.26

 Hypertension

5 (16.7)

25 (83.3)

0.39

0.13–1.12

0.080

 Coronary heart disease

2 (18.2)

9 (81.8)

0.50

0.10–2.47

0.40

 Diabetes

2 (18.2)

9 (81.8)

0.50

0.10–2.47

0.40

 Others

1 (50.0)

1 (50.0)

2.45

0.15–40.43

0.53

 Solid tumors

24 (26.1)

68 (73.9)

REF

 Hematological malignancies

8 (50.0)

8 (50.0)

2.83

0.96–8.38

0.06

 No

21 (27.6)

55 (72.4)

REF

 Yes

3 (17.7)

14 (82.4)

0.56

0.15–2.15

0.40

 0

3 (4.6)

63 (95.5)

REF

 1

8 (44.4)

10 (55.6)

16.80

3.81–74.19

0.0002^a

  ≥ 2

21 (84.0)

4 (16.0)

110.25

22.79–533.29

< 0.0001^a

  ≥ 20 kg/m²

5 (17.2)

24 (82.8)

REF

  < 20 kg/m²

3 (33.3)

6 (66.7)

2.40

0.44–12.98

0.31

 Yes

11 (22.0)

39 (78.0)

REF

 No

2 (11.1)

16 (88.9)

0.44

0.09–2.23

0.32

< 1 year

3 (21.4)

11 (78.6)

2.18

0.19–25.00

0.53

 1–4 years

6 (20.7)

23 (79.3)

2.09

0.22–20.08

0.52

 5–9 years

22 (38.6)

35 (61.4)

5.03

0.59–42.97

0.14

  ≥ 10 years

1 (11.1)

8 (88.9)

REF